Skip to main content

CMO Supplier Quality Agreements :- How to Comply with new FDA and EU Guidelines for Contract Drug Manufacturer

Compliance Key INC - Compliance Online Training


                                           Roger Cowan
Roger Cowan is the Keynote Spaker at Compliance Key Inc. He is the founder and owner of R Cowan Consulting Services LLC, a consulting company specializing primarily in the area of pharmaceutical contract manufacturing. He has 35 years experience in pharmaceutical quality assurance and manufacturing.
 Webinar Id: LSHCRC007
 10:00 AM PT | 01:00 PM ET
 12/07/2017
 Duration 60 mins
Overview
A Quality Agreement is a contract between a pharmaceutical firm and a GMP Contract Manufacturer detailing the responsibilities of each party in assuring the quality, safety, and efficacy of the manufactured drug. 
Recently, the EU and the FDA issued regulatory guidance to bring some clarity and consistency to these quality contracts:
  • EU GMP Chapter 7 "Outsourced Activities" (Revised)
  • Draft Guidance for Industry -"Contract Manufacturing Arrangements for Drugs: Quality Agreements" May 2013
Why should you attend this webinar?
In 2010, the global CMO market was estimated at $26 billion dollars. Year on year growth has been 10.7% since 2008. The increasing use of outsourcing in the pharmaceutical industry along with recent well-publicized quality issues with CMOs, make it a necessity to have excellent quality oversight of external manufacturers to provide assurance of GMP compliance. A Quality Agreement is one tool used to accomplish this objective. 
This Webinar presentation will provide a thorough understanding of the content that is expected in Quality Agreements from a regulatory perspective. 
Control of suppliers such as Contract Manufacturing Organizations has always been a requirement of the FDA and EU. With the issuance of these new regulatory documents; the expectation is that there will be a written documentation of this control. Proof of this control can be presented to FDA / EU inspectors in the form of a Quality Agreement which is specific to a particular CMO. 
Each proposed section of a Quality Agreement is fully analyzed and suggested content is written with the new guidelines taken into consideration. Comparison of the two regulatory documents is presented with differences highlighted and discussed.
A detailed discussion of Quality Agreement topics such as change control, documentation, facilities, and equipment, lab controls, sub-contracting, etc. is covered. 
The latest status of the FDA draft guidance is discussed and a review of comments from industry is included.
Areas Covered in the Session:
  • The Who and What of a good Quality Agreement
  • What a Quality Agreement is - and is not
  • Responsibilities of the owner vs. contract facility
  • GMP responsibilities
  • A comparison of the new guidelines from the FDA and the EU
Who can Benefit:
  • Quality Assurance
  • External Manufacturing / Outsourcing
  • Quality Auditing
  • Technology Transfer
  • Regulatory Affairs / Compliance 
  • Supply Chain
  • Purchasing
  • Risk Management
 Compliance Key INC
Labels:
Location: United States

Comments

Post a Comment

Popular posts from this blog

Conducting a Software Validation of Medical Device to Meet FDA Requirements

Compliance Key INC -  Medical Device Training                                           Edwin Waldbusser Ed is Keynote Speaker at Compliance key Inc . He is retired from industry after 30 years in management of development of medical device products and development of company Quality Systems. Products included IVD devices, kidney dialysis systems and inhalation devices. QS experience includes design control, risk analysis, CAPA, software validation, supplier qualification/ control and manufacturing.   Webinar Id:  LSHCMEW007  10.00 AM PT | 01.00 PM ET  12/04/2017   Duration 90 mins  Overview This course will teach how to conduct a software validation program that will satisfy FDA requirements and produce a safe product. Software validation is much more than testing.We will explain the role of risk analysi...
Post a Comment
Read more

Building a Compliance Program

Compliance Key INC  -  Compliance Training Webinar                                   Lisa M. Marsden Lisa M. Marsden, IACCP, is Keynote speaker at Compliance Key, Inc. She is the president and founder of Coulter Strategic Services. Coulter Strategic Services provides financial advisors and consulting firms with compliance and project management services. Prior to that, Ms. Marsden was the chief operating officer/chief compliance officer of Financial Trust Asset Management, Boca Raton, Florida.  Webinar Id:  CICLB005  10:30 AM PT | 01:00 PM ET  05/15/2018  Duration 60 mins  Overview Whether you are creating a new compliance program as a new CCO or a new firm or if you are updating an existing program this webinar will guide you through the process. Why should you attend this webinar? Rule 17j-1. Effective Date: A...
Post a Comment
Read more

Understanding Design Controls

Compliance Key INC  -  Medical Device Training Overview Design Controls are the processes used to design, develop, and manage medical devices that you manufacture. They are mandated by federal regulation, however, the regulations concerning design controls are vague in terms of the specific process steps required and the approaches that should be taken to achieve compliance should be developed. Knowing how the FDA both views and examines design controls is crucial to achieving compliance throughout the life of the medical devices you manufacture and is one of the most valuable compliance subject areas to explore. Noncompliance in design controls, which are consistently uncovered by the FDA during inspections and examinations, are concerned with the design control process that has been designed and applied and the documentation required to support each design control step. The specific sections of the regulations that apply to design controls include CFR 21 Part 820 Qua...
1 comment
Read more